SPL News: Active agent in Australian-developed nasal spray >99.5% active against the Omicron SARS-CoV-2 varian - 1st Mar 2022, 7:44pm

annb0t

Top 20
The antiviral agent in VIRALEZE™ antiviral nasal spray, SPL7013, achieved >99.5% reduction of virus infectivity (the maximal possible reduction) against the highly contagious Omicron variant of SARS-CoV-2 SPL7013 showed potent antiviral activity and was virucidal against the Omicron variant SPL7013 outperformed other antiviral agents used in marketed nasal sprays, including iota-carrageenan and nitric oxide, in the studies conducted at The Scripps Research Institute The potent activity of S...

>>> Read more: Active agent in Australian-developed nasal spray >99.5% active against the Omicron SARS-CoV-2 variant
 
Top Bottom